As the demand for precise analytical data in the biotechnology sector reaches new heights, Lyze Labs is positioning itself as ...
Step inside Natasha Sheybani’s office at the University of Virginia, where she runs a bioengineering lab, and you’ll find a kaleidoscopic sea of sticky notes. She uses purple for ideas sparked by ...
Ella Zhang of YZi Labs says her firm invests in founders building what doesn’t yet exist, guided by first principles and long ...
Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, ...
NVIDIA (NasdaqGS:NVDA) is expanding its AI reach through new partnerships in industrial virtual twins with Dassault Systèmes.
BioAge Labs is bringing in almost $200 million via its Nasdaq IPO this morning, with the proceeds earmarked for taking its lead obesity drug further into clinical trials. After setting out plans ...
BioAge Labs is eyeing around $180 million in initial proceeds from an IPO and a private placement, funds the metabolic-focused biotech will use to push its lead obesity prospect through the clinic.
NORTHAMPTON, MA / ACCESS Newswire / April 4, 2025 / In the biotechnology sector, innovation extends beyond medical discoveries to include approaches for managing environmental impact. For example, non ...
Westchester County's life science industry has been growing for decades, thanks to the county's proximity to New York City, its assets in health care, access to a varied workforce and more. But future ...
Two biotechs take full floors at Waltham’s GENESIS 21 Hickory — about 48K sq ft added to the Route 128 lab campus.
Despite the headline jump, local brokers describe a market that still feels slow. As reported by Crain's New York Business, CBRE Vice Chairman William Hartman said demand is "still pretty anemic" even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results